摘要 |
<p>The present invention provides methods for treating inflammatory diseases, neoplastic diseases, wound healing and preventing scarring by administering a therapeutically effective amount of phosphoglycerate phosphokinase (PGK) peptide, polypeptide, protein, mutant or mimetic to a subject. The invention also relates to methods of screening for compounds for modulation of uPAR expression or activity. The present invention further provides coding sequences of phosphoglycerate kinase peptides, polypeptides, or proteins, or mutants, or mimetics thereof as a gene therapy for inflammatory diseases, cancer, wound healing, or tissue scarring.</p> |
申请人 |
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM;SHETTY, SREERAMA;IDELL, STEVEN |
发明人 |
SHETTY, SREERAMA;IDELL, STEVEN |